ADORE // Study to Investigate the Efficacy and Safety of FAB122 (Daily Oral Edaravone) in Patients With ALS SLAPhase 3 Completed
AB19001 // Efficacy and Safety of Masitinib Versus Placebo in the Treatment of ALS Patients SLAPhase 3 Suspended recruitment
